Literature DB >> 2069905

Geographic heterogeneity of neoplasia-associated chromosome aberrations.

B Johansson1, F Mertens, F Mitelman.   

Abstract

Using a database comprising 13,266 cytogenetically abnormal neoplasms, the geographic heterogeneity of neoplasia-associated chromosomal abnormalities was investigated by comparing the frequencies of characteristic aberrations in consecutive series of patients with the same diagnosis. Significant frequency differences between geographic areas were found for the aberrations +8, i(17q), +19, and an additional Ph1 chromosome in chronic myeloid leukemia (CML); -5, 5q-, and +8 in acute nonlymphocytic leukemia (ANLL); t(8;21) in ANLL-M2; t(15;17) in ANLL-M3; 5q- and -7 in myelodysplastic syndromes (MDS); t(9;22) and +21 in acute lymphocytic leukemia (ALL); t(14;18) in follicular lymphoma; -8 and -22/22q- in meningioma; and structural abnormalities of 12q in pleomorphic adenoma of the salivary glands (PAS). No geographic incidence variation was detected for -7 and +21 in ANLL; +8 in MDS; 6q- and +8 in ALL; +12 in chronic lymphocytic leukemia; 6q- in non-Hodgkin's lymphoma (NHL); t(8;14) in Burkitt's lymphoma; t(11;22) in Ewing's sarcoma; i(12p) in germ cell tumors; 1p- in neuroblastoma; structural abnormalities of 3q, 8q, and 9p in PAS; or 3p- in renal cell carcinoma. Intraregional frequency similarities between cytogenetically identical abnormalities in related tumor types were also analyzed. No significant correlations were found regarding the incidence of 5q- in ANLL and MDS, 6q- in ALL and NHL, -7 in ANLL and MDS, +8 in ANLL and CML, +8 in ANLL and MDS, +8 in ALL and ANLL, or +21 in ALL and ANLL. The findings indicate that some geographic heterogeneity of tumor-associated aberrations exists both in hematologic neoplasms and in solid tumors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2069905     DOI: 10.1002/gcc.2870030102

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

Authors:  Pamela L Kunz; Amirkaveh Mojtahed; George A Fisher; James M Ford; Daniel T Chang; Raymond R Balise; Charles D Bangs; Athena M Cherry; Reetesh K Pai
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-01

3.  A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia.

Authors:  Fábio Morato de Oliveira; Leonardo de Carvalho Palma; Roberto Passetto Falcão; Belinda Pinto Simões
Journal:  Med Oncol       Date:  2011-12-31       Impact factor: 3.064

4.  Geographic heterogeneity of the AML1-ETO fusion gene in Iranian patients with acute myeloid leukemia.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzaeh Colagar
Journal:  Rep Biochem Mol Biol       Date:  2014-10

5.  Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases.

Authors:  Liming Bao; Sherilyn A Gross; John Ryder; Xiaoqin Wang; Meirong Ji; Yan Chen; Yongchen Yang; Saijuan Zhu; Richard D Irons
Journal:  Int J Hematol       Date:  2009-03-26       Impact factor: 2.490

6.  Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients.

Authors:  J C Aster; Y Kobayashi; M Shiota; S Mori; J Sklar
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.

Authors:  Rekha Chaubey; Sudha Sazawal; Rima Dada; Manoranjan Mahapatra; Renu Saxena
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

8.  Rapid detection of prognostically significant fusion transcripts in acute leukemia using simplified multiplex reverse transcription polymerase chain reaction.

Authors:  Young-Uk Cho; Hyun-Sook Chi; Chan-Jeoung Park; Seongsoo Jang; Eul-Ju Seo
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

9.  Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens.

Authors:  Salah Abbasi; Faten Maleha; Muhannad Shobaki
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-04-10       Impact factor: 2.576

10.  Cytogenetic risk groups for childhood acute myeloid leukemia based on survival analysis in a cancer referral hospital from Perú

Authors:  Yesica Llimpe
Journal:  Biomedica       Date:  2021-06-29       Impact factor: 0.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.